Ex Vivo Oncolytic Virotherapy with Myxoma Virus Arms Multiple Allogeneic Bone Marrow Transplant Leukocytes to Enhance Graft versus Tumor

Allogeneic stem cell transplant-derived T cells have the potential to seek and eliminate sites of residual cancer that escaped primary therapy. Oncolytic myxoma virus (MYXV) exhibits potent anti-cancer efficacy against human cancers like multiple myeloma (MM) and can arm transplant-derived T cells t...

Descripción completa

Detalles Bibliográficos
Autores principales: Lilly, Cameron L., Villa, Nancy Y., Lemos de Matos, Ana, Ali, Haider M., Dhillon, Jess-Karan S., Hofland, Tom, Rahman, Masmudur M., Chan, Winnie, Bogen, Bjarne, Cogle, Christopher, McFadden, Grant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363758/
https://www.ncbi.nlm.nih.gov/pubmed/28345022
http://dx.doi.org/10.1016/j.omto.2016.12.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363758/
https://www.ncbi.nlm.nih.gov/pubmed/28345022
http://dx.doi.org/10.1016/j.omto.2016.12.002

Ejemplares similares